Image via Wikipedia The Columbia Daily Tribune "Since his diagnosis, Harris had been following Pfizer’s clinical trials for a new drug called crizotinib, available under the brand name Xalkori.Ramaswamy Govindan, a professor in the division of medical oncology at the Washington University School of Medicine in St. Louis who conducted the study, said early tests found crizotinib to be effective in treating a specific type of lung cancer characterized by the presence of a protein called anaplastic lymphoma kinase, or ALK. This ALK protein causes cell mutations that become lung cancer. Govindan said crizotinib works by turning the protein off."
0 comments:
Post a Comment